89 related articles for article (PubMed ID: 20556477)
21. The role of surgery in intracranial PCNSL.
Jahr G; Da Broi M; Holte H; Beiske K; Meling TR
Neurosurg Rev; 2018 Oct; 41(4):1037-1044. PubMed ID: 29383600
[TBL] [Abstract][Full Text] [Related]
22. Relapsed or refractory primary central nervous system lymphoma radiosurgery: Report of the International Gamma Knife Research Foundation.
Shin SM; Silverman JS; Bowden G; Mathieu D; Yang HC; Lee CC; Tam M; Szelemej P; Kaufmann AM; Cohen-Inbar O; Sheehan J; Niranjan A; Lunsford LD; Kondziolka D
J Radiosurg SBRT; 2017; 4(4):247-253. PubMed ID: 29296450
[TBL] [Abstract][Full Text] [Related]
23. The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
Mendez JS; Ostrom QT; Gittleman H; Kruchko C; DeAngelis LM; Barnholtz-Sloan JS; Grommes C
Neuro Oncol; 2018 Apr; 20(5):687-694. PubMed ID: 29036697
[TBL] [Abstract][Full Text] [Related]
24. Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma.
Fan N; Zhang L; Xu X; Chen B; Zhu C; Li P; Chen Z; Ding T; Ma Y; Yuan Y; Lin Z
Oncotarget; 2017 Aug; 8(32):53701-53713. PubMed ID: 28881844
[TBL] [Abstract][Full Text] [Related]
25. Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients.
Mahale P; Shiels MS; Lynch CF; Engels EA
Am J Transplant; 2018 Feb; 18(2):453-461. PubMed ID: 28805292
[TBL] [Abstract][Full Text] [Related]
26. The Challenge of Primary Central Nervous System Lymphoma.
Carnevale J; Rubenstein JL
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1293-1316. PubMed ID: 27888882
[TBL] [Abstract][Full Text] [Related]
27. Trends in primary central nervous system lymphoma incidence and survival in the U.S.
Shiels MS; Pfeiffer RM; Besson C; Clarke CA; Morton LM; Nogueira L; Pawlish K; Yanik EL; Suneja G; Engels EA
Br J Haematol; 2016 Aug; 174(3):417-24. PubMed ID: 27018254
[TBL] [Abstract][Full Text] [Related]
28. Modern techniques of magnetic resonance in the evaluation of primary central nervous system lymphoma: contributions to the diagnosis and differential diagnosis.
da Rocha AJ; Sobreira Guedes BV; da Silveira da Rocha TM; Maia Junior AC; Chiattone CS
Rev Bras Hematol Hemoter; 2016; 38(1):44-54. PubMed ID: 26969774
[TBL] [Abstract][Full Text] [Related]
29. Partial-brain radiotherapy for primary central nervous system lymphoma: multi-institutional experience.
Iwabuchi M; Shibamoto Y; Sugie C; Ayakawa S; Ogino H; Baba F
J Radiat Res; 2016 Mar; 57(2):164-8. PubMed ID: 26661856
[TBL] [Abstract][Full Text] [Related]
30. New approaches in primary central nervous system lymphoma.
Fraser E; Gruenberg K; Rubenstein JL
Chin Clin Oncol; 2015 Mar; 4(1):11. PubMed ID: 25841718
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
[TBL] [Abstract][Full Text] [Related]
32. Progress in central nervous system lymphomas.
Wang CC; Carnevale J; Rubenstein JL
Br J Haematol; 2014 Aug; 166(3):311-25. PubMed ID: 24837460
[TBL] [Abstract][Full Text] [Related]
33. Factors associated with survival among patients with AIDS-related primary central nervous system lymphoma.
Uldrick TS; Pipkin S; Scheer S; Hessol NA
AIDS; 2014 Jan; 28(3):397-405. PubMed ID: 24076659
[TBL] [Abstract][Full Text] [Related]
34. How I treat CNS lymphomas.
Rubenstein JL; Gupta NK; Mannis GN; Lamarre AK; Treseler P
Blood; 2013 Oct; 122(14):2318-30. PubMed ID: 23963042
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in treatment of primary central nervous system lymphoma.
Nayak L; Batchelor TT
Curr Treat Options Oncol; 2013 Dec; 14(4):539-52. PubMed ID: 23934511
[TBL] [Abstract][Full Text] [Related]
36. The role of host gender in the pathogenesis of Cryptococcus neoformans infections.
McClelland EE; Hobbs LM; Rivera J; Casadevall A; Potts WK; Smith JM; Ory JJ
PLoS One; 2013; 8(5):e63632. PubMed ID: 23741297
[TBL] [Abstract][Full Text] [Related]
37. Brain efflux index to investigate the influence of active efflux on brain distribution of pemetrexed and methotrexate.
Li L; Agarwal S; Elmquist WF
Drug Metab Dispos; 2013 Mar; 41(3):659-67. PubMed ID: 23297298
[TBL] [Abstract][Full Text] [Related]
38. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma.
Villano JL; Koshy M; Shaikh H; Dolecek TA; McCarthy BJ
Br J Cancer; 2011 Oct; 105(9):1414-8. PubMed ID: 21915121
[TBL] [Abstract][Full Text] [Related]
39. Pharmacotherapy for primary CNS lymphoma: progress beyond methotrexate?
Graber JJ; Omuro A
CNS Drugs; 2011 Jun; 25(6):447-57. PubMed ID: 21649446
[TBL] [Abstract][Full Text] [Related]
40. Survival among patients with primary central nervous system lymphoma, 1973-2004.
Norden AD; Drappatz J; Wen PY; Claus EB
J Neurooncol; 2011 Feb; 101(3):487-93. PubMed ID: 20556477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
